ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 60 filers reported holding ESSA PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,101,585 | +14.4% | 356,500 | 0.0% | 0.12% | +17.8% |
| Q2 2023 | $962,550 | -8.5% | 356,500 | 0.0% | 0.10% | -12.2% |
| Q1 2023 | $1,051,675 | +11.3% | 356,500 | -4.9% | 0.12% | +16.2% |
| Q4 2022 | $945,000 | -30.0% | 375,000 | 0.0% | 0.10% | -29.8% |
| Q3 2022 | $1,350,000 | +14.3% | 375,000 | 0.0% | 0.14% | +5.2% |
| Q2 2022 | $1,181,000 | -53.5% | 375,000 | -8.7% | 0.13% | -46.6% |
| Q1 2022 | $2,540,000 | -57.1% | 410,923 | -2.2% | 0.25% | -36.3% |
| Q4 2021 | $5,926,000 | +23.5% | 420,000 | -30.0% | 0.39% | +16.9% |
| Q3 2021 | $4,800,000 | -35.4% | 600,000 | +130.8% | 0.34% | -33.1% |
| Q2 2021 | $7,428,000 | -1.7% | 260,000 | 0.0% | 0.50% | -4.4% |
| Q1 2021 | $7,553,000 | +304.1% | 260,000 | +65.9% | 0.53% | +246.7% |
| Q4 2020 | $1,869,000 | – | 156,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
| BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
| PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
| Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
| Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
| Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
| Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |